JP2023538859A5 - - Google Patents
Info
- Publication number
- JP2023538859A5 JP2023538859A5 JP2023509769A JP2023509769A JP2023538859A5 JP 2023538859 A5 JP2023538859 A5 JP 2023538859A5 JP 2023509769 A JP2023509769 A JP 2023509769A JP 2023509769 A JP2023509769 A JP 2023509769A JP 2023538859 A5 JP2023538859 A5 JP 2023538859A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- levodopa
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063072661P | 2020-08-31 | 2020-08-31 | |
| US63/072,661 | 2020-08-31 | ||
| PCT/US2021/048218 WO2022047298A1 (en) | 2020-08-31 | 2021-08-30 | Compositions and methods for levodopa delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538859A JP2023538859A (ja) | 2023-09-12 |
| JP2023538859A5 true JP2023538859A5 (cg-RX-API-DMAC7.html) | 2024-09-05 |
Family
ID=80354133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509769A Pending JP2023538859A (ja) | 2020-08-31 | 2021-08-30 | レボドパ送達のための組成物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230181508A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4203939A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023538859A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022047298A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2328614C (en) * | 1999-02-12 | 2012-06-26 | Biostream, Inc. | Matrices for drug delivery and methods for making and using the same |
| AR044007A1 (es) * | 2003-04-11 | 2005-08-24 | Newron Pharmaceuticals Inc | Metodos para el tratamiento de la enfermedad de parkinson |
| CA2657953A1 (en) * | 2005-07-19 | 2007-01-25 | University Of Rochester | Alpha-synuclein antibodies and methods related thereto |
| WO2010009557A1 (en) * | 2008-07-25 | 2010-01-28 | Sanomune Inc. | Tissue kallikrein for the treatment of parkinson's disease |
| PT3192500T (pt) * | 2009-05-19 | 2021-01-05 | Neuroderm Ltd | Composições para a administração contínua de inibidores da dopa decarboxilase |
| US20130253056A1 (en) * | 2009-05-19 | 2013-09-26 | Neuroderm, Ltd. | Continuous Administration of Levodopa and/or Dopa Decarboxylase Inhibitors and Compositions for Same |
| TW201304822A (zh) * | 2010-11-15 | 2013-02-01 | Vectura Ltd | 組成物及用途 |
| DK2640358T3 (en) * | 2010-11-15 | 2018-04-16 | Neuroderm Ltd | CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA-DECARBOXYLASE INHIBITORS, CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND COMPOSITIONS THEREOF |
| HUE056006T2 (hu) * | 2013-03-13 | 2022-01-28 | Neuroderm Ltd | Kombináció Parkinson-kór kezelésére |
| US11278682B2 (en) * | 2014-11-09 | 2022-03-22 | Sipnose Ltd. | Device and method for aerosolized delivery of substance to a natural orifice of the body |
| EP3735298A4 (en) * | 2018-01-05 | 2021-10-06 | Impel Neuropharma Inc. | INTRANASAL ADMINISTRATION OF LEVODOPA POWDER BY N BY AN OLFACTORIC PRECISION DEVICE |
| WO2019147934A1 (en) * | 2018-01-29 | 2019-08-01 | Sackner Bernstein Jonathan | Methods for dopamine modulation in human neurologic diseases |
-
2021
- 2021-08-30 WO PCT/US2021/048218 patent/WO2022047298A1/en not_active Ceased
- 2021-08-30 EP EP21862913.7A patent/EP4203939A4/en active Pending
- 2021-08-30 JP JP2023509769A patent/JP2023538859A/ja active Pending
- 2021-08-30 US US18/017,767 patent/US20230181508A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009543761A (ja) | レボドパ/カルビドパの長期間24時間腸内投与 | |
| JP3623962B2 (ja) | ヒドロキソコバラミンの鼻中投与用医薬組成物 | |
| JP2023507094A5 (cg-RX-API-DMAC7.html) | ||
| CN105120856A (zh) | 用于改善肺功能和用于预防和/或治疗辐射诱发的肺并发症的材料和方法 | |
| US9861647B2 (en) | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions | |
| US9592291B2 (en) | Methods for iontophoretically treating nausea and migraine | |
| JP2023500032A5 (cg-RX-API-DMAC7.html) | ||
| RU2019111715A (ru) | Окисляющие аммиак микроорганизмы для применения и доставки в интраназальной системе | |
| Pandey et al. | Efficacy of transdermal ketoprofen patch in comparison to transdermal diclofenac patch in postoperative analgesia for orthodontic extractions: a randomized split-mouth study | |
| JP2023500360A5 (cg-RX-API-DMAC7.html) | ||
| JP2019516797A5 (cg-RX-API-DMAC7.html) | ||
| JP2024501235A5 (cg-RX-API-DMAC7.html) | ||
| KR101896441B1 (ko) | 국소투여형의 연하장애 개선용 의약품 | |
| JP2025516040A (ja) | 鼻腔内バクロフェン | |
| JP2021530568A5 (cg-RX-API-DMAC7.html) | ||
| CN106507666A9 (zh) | 1,3‑丙二磺酸或其药学上可接受的盐用于治疗肉样瘤病的用途 | |
| WO2023059716A8 (en) | Compositions and methods for levodopa delivery | |
| JP2022071083A (ja) | うつ病を予防または治療するための安息香酸またはその塩および誘導体 | |
| US20210353563A1 (en) | Composition and method for treatment of respiratory disorders | |
| RU2345760C1 (ru) | Способ лечения расстройства полового влечения (либидо) у мужчин | |
| US11819508B2 (en) | Miltefosine for the treatment of viral infections including covid-19 | |
| RU2200561C1 (ru) | Способ лечения и профилактики заболеваний | |
| RU2345778C1 (ru) | Способ лечения расстройств эрекции у мужчин | |
| RU2192255C2 (ru) | Способ лечения хронических и подострых тиреоидитов | |
| WO2023210617A1 (ja) | パーキンソン病治療用医薬組成物 |